 VANCOUVER, BC and HOUSTON, Feb. 17, 2021 PRNewswire - ESSA Pharma Inc. ESSA, or the Company Nasdaq: EPIX, a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the pricing of an underwritten public... 